Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
02/2009
02/05/2009WO2009016839A1 Method for measurement of concentration of antigen
02/05/2009WO2009016770A1 Hybridization method and apparatus
02/05/2009WO2009016691A1 Cancer associated gene ly6k
02/05/2009WO2009016627A1 Sex-peptides resistant to proteolytic degradation and their use in biological control of insects
02/05/2009WO2009016326A2 Adeno-associated viral vectors for the expression of dysferlin
02/05/2009WO2009016249A2 Transgenic plants with increased stress tolerance and yield
02/05/2009WO2009016232A2 Plants having enhanced yield-related traits and a method for making the same
02/05/2009WO2009016212A2 Plants having enhanced yield-related traits and a method for making the same
02/05/2009WO2009016208A2 Elongases and methods for producing polyunsaturated fatty acids in transgenic organisms
02/05/2009WO2009016206A1 Insulating polynucleotides derived from element d4z4 and their uses in transgenesis
02/05/2009WO2009016202A2 Desaturases and methods for producing polyunsaturated fatty acids in transgenic organisms
02/05/2009WO2009016178A1 Methods and substances for the treatment of alzheimer's
02/05/2009WO2009016166A1 Maize having improved digestibility
02/05/2009WO2009016110A1 Process for separating nonproteinaneous biomolecules, in particular nucleic acids, from proteinaneous samples
02/05/2009WO2009016104A1 Plants having enhanced yield-related traits and a method for making the same
02/05/2009WO2009015840A2 Polypeptide for targeting of neural cells
02/05/2009WO2009015623A1 Biological effect monitoring by means of transgenic hydra
02/05/2009WO2009015505A1 Interactions between plant species separated by species barriers and uses thereof
02/05/2009WO2009015491A1 Umps isoforms as novel predictive markers and therapeutic targets for chemotherapeutics
02/05/2009WO2009015484A1 Concentration and enrichment of microbial cells and microbial nucleic acids from bodily fluids
02/05/2009WO2009015479A1 Genetic variation in pro-melanin-concentrating hormone gene affects carcass traits in cattle
02/05/2009WO2009015478A1 Bacterial isolate and methods for detoxification of trichothecene mycotoxins
02/05/2009WO2008154098A9 Reagents and methods for mirna expression analysis and identification of cancer biomarkers
02/05/2009WO2008153934A3 Methods for improving protein performance
02/05/2009WO2008153742A3 Methods and compositions for increased transgene expression
02/05/2009WO2008151049A3 Nucleic acid functionalized nanoparticles for therapeutic applications
02/05/2009WO2008150814A3 Methods for production and uses of multipotent cell populations
02/05/2009WO2008145133A3 Method for manufacturing a recombinant polyclonal protein
02/05/2009WO2008144485A3 Inhibition of palmitoyl acyl transferase expression and/or activity for the regulation of antiproliferative factor activity
02/05/2009WO2008141154A3 Novel herbicide resistance genes
02/05/2009WO2008137775A3 RNA INTERFERENCE MEDIATED INHIBITION OF CYCLIC NUCLEOTIDE TYPE 4 PHOSPHODIESTERASE (PDE4B) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
02/05/2009WO2008137771A3 RNA INTERFERENCE MEDIATED INHIBITION OF CYCLIC NUCLEOTIDE TYPE 4 PHOSPHODIESTERASE ( PDE4B) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
02/05/2009WO2008124048A3 Multizymes and their use in making polyunsaturated fatty acids
02/05/2009WO2008122886A3 Transgenic non-human mammal with homodimeric vh binding complex
02/05/2009WO2008121813A3 Modulation of cytokine production
02/05/2009WO2008112459A3 Alkaliphilic bacillus species a-amylase variants, compositions comprising a-amylase variants, and methods of use
02/05/2009WO2008109558A3 Nucleic acid compounds for inhibiting tlr gene expression and uses thereof
02/05/2009WO2008109531A3 Nucleic acid compounds for inhibiting hsd11b1 expression and uses thereof
02/05/2009WO2008104890A3 Compositions and methods for producing apolipoprotein
02/05/2009WO2008100482A3 Peptides that target to tumor blood vessels of lung cancer and applications thereof
02/05/2009WO2008059043A3 Combination of coagulation factor viii with apc-resistant factor v
02/05/2009WO2008054726A3 Targeting nbs1-atm interaction to sensitize cancer cells to radiotherapy and chemotherapy
02/05/2009WO2008054606A3 High affinity human antibodies to human il-4 receptor
02/05/2009WO2008036341A3 Compositions and methods relating to glucagon receptor antibodies
02/05/2009WO2007020638A3 Methods of increasing abiotic stress tolerance and/or biomass in plants and plants generated thereby
02/05/2009WO2006124752A3 High grain protein content gene
02/05/2009US20090038034 Polynucleotides Encoding Stop Codons in Multiple Reading Frames and Methods of Use
02/05/2009US20090038033 Wood and cell wall gene microarray
02/05/2009US20090038032 Method for producing transgenic plants
02/05/2009US20090038031 Axmi-028 and axmi-029, a family of novel delta-endotoxin genes and methods for their use
02/05/2009US20090038030 Homologous recombination-mediated transgene deletion in plant cells
02/05/2009US20090038029 Method to alleviate abiotic stress in plants
02/05/2009US20090038027 Msca1 nucleotide sequences impacting plant male fertility and method of using same
02/05/2009US20090038026 Msca1 nucleotide sequences impacting plant male fertility and method of using same
02/05/2009US20090038025 Selection system for maize transformation
02/05/2009US20090038023 Lyase Enzymes, Nucleic Acids Encoding Them and Methods For Making and Using Them
02/05/2009US20090038022 IGF-1 Novel peptides
02/05/2009US20090038020 Human albumin animal models for drug evaluation, toxicology and immunogenicity studies
02/05/2009US20090036695 Oil Biosynthesis
02/05/2009US20090036663 isothermal amplification of RNA; useful for preparation of nucleic acid libraries and substrates for analysis of gene expression of cells in biological samples; Generation of preferential nucleotide sequences; obtain nucleic acid template, incubate with primer, amplify, separate and recover
02/05/2009US20090036661 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
02/05/2009US20090036648 EGVI Endoglucanase and Nucleic Acids Encoding the Same
02/05/2009US20090036398 Human G-Protein Coupled Receptor (HETGQ23)
02/05/2009US20090036397 RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF MACULAR EDEMA
02/05/2009US20090036396 RNAi-RELATED INHIBITION OF TNFalpha SIGNALING PATHWAY FOR TREATMENT OF OCULAR ANGIOGENESIS
02/05/2009US20090036395 Rna interference suppression of neurodegenerative diseases and methods of use thereof
02/05/2009US20090036394 GRP 146 Receptor
02/05/2009US20090036393 Vesicular monoamine transporter gene therapy in Parkinson's disease
02/05/2009US20090036391 Modulation of line-1 reverse transcriptase
02/05/2009US20090036378 Use of Factor VIIa or a Tissue Factor Antagonist for Regulating Gene Expression and Cell Migration or Chemotaxis
02/05/2009US20090036374 Hepatocyte growth factor receptor splice variants and methods of using same
02/05/2009US20090036370 Leukocyte Adhesion Inhibitor-1 (LAI-1)
02/05/2009US20090036367 Novel peptides of the respiratory syncytial virus (RSV) G protein and their use in a vaccine
02/05/2009US20090036366 Inhibitors of human plasmin derived from the kunitz domains
02/05/2009US20090036365 Inhibitors of human plasmin derived from the kunitz domains
02/05/2009US20090036362 Angiogenesis Affecting Polypeptides, Proteins, and Composition, and Methods of Use Thereof
02/05/2009US20090036358 Methods of preparing pharmaceutical compositions for treatment of factor Vlll associated disorders and methods of use
02/05/2009US20090036318 Class II Human Histone Deacteylases, and Uses Related Thereto
02/05/2009US20090036307 Use of bacteriophage outer membrane breaching proteins expressed in plants for the control of gram-negative bacteria
02/05/2009US20090035864 Plasmids for transforming bacteria of the acidithiobacillus spp. genus, and transformation method
02/05/2009US20090035863 Method for the deletion of a large chromosomal region
02/05/2009US20090035862 Methods and compositions for genomic modification
02/05/2009US20090035861 RNAi Medicine Having No Adverse Effects
02/05/2009US20090035854 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
02/05/2009US20090035853 Tsg101-gag interaction and use thereof
02/05/2009US20090035839 Metabolically engineered cells for the production of resveratrol or an oligomeric or glycosidically-bound derivative thereof
02/05/2009US20090035827 O-acetyltransferase from Neisseria Meningitidis, Compositions and Methods
02/05/2009US20090035823 Ligation-based synthesis of oligonucleotides with block structure
02/05/2009US20090035822 Fusion Proteins
02/05/2009US20090035821 Expression of Proteins in E.Coli
02/05/2009US20090035820 Nucleic acid constructs, expression vectors, and recombinant host cells comprising such nucleotide sequences; detergents; leather; food; dairyproducts; drugs; cheeses; tanning; cost efficiency; industrial scale
02/05/2009US20090035819 CA125 gene and its use for diagnostic and therapeutic interventions
02/05/2009US20090035818 Novel Polypeptide, Polynucleotide Encoding the Polypeptide and Use the Polypeptide and Polynucleotide
02/05/2009US20090035815 Synthetic Gene for Enhanced Expression in E. Coli
02/05/2009US20090035799 Novel trypsin family serine proteases
02/05/2009US20090035788 Genetically encoded bioindicators of calcium-ions
02/05/2009US20090035783 Fluorescent proteins and uses thereof
02/05/2009US20090035773 Nucleic acid sequences for detecting genetic markers for cancer in a biological sample
02/05/2009US20090035771 gene expression; probes, primers, antibodies
02/05/2009US20090035761 Method for isolation of DNA, RNA and proteins from formalin-fixed paraffin-embedded tissue specimens